BioSpace News Archive

Genetown

Boston Scientific Announces Upcoming Conference Schedule - Nov 08, 2021

On November 15, 2021, Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual 2021 Stifel Healthcare Conference.

November 8, 2021
·
1 min read
BioMidwest

Melzi Sharps Finder(TM) Demonstrates Improved Ability to Locate Retained Surgical Sharps (RSS)

Melzi Surgical, a surgical device company dedicated to creating innovative technologies that improve patient outcomes while reducing hospital expenses, announced a report evaluating the Company’s lead product, the Sharps Finder™.

November 8, 2021
·
4 min read
Pharm Country

Olympus supports new guidelines for annual preventative lung cancer screenings

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced its support for new lung cancer screening guidelines that could open more at-risk individuals to potentially life-saving scans.

November 8, 2021
·
5 min read
Drug Development

Alligator Bioscience Announces Commencement of Investigator Initiated Phase I Clinical Trial at Erasmus University Rotterdam

First Patient Dosed in Study Evaluating Mitazalimab in Combination with Cancer Vaccine for Patients with Pancreatic Cancer

November 8, 2021
·
3 min read
Business

Nordic Nanovector appoints experienced biotech executive Pierre Dodion MD as Chief Medical Officer

Nordic Nanovector ASA (OSE: NANO) announces the appointment of Pierre Dodion MD as Chief Medical Officer (CMO)

November 8, 2021
·
5 min read
Press Releases

New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies’ CleanCap® technology for mRNA synthesis

New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), CleanCap Reagent AG.

November 8, 2021
·
4 min read
Deals

Mainz Biomed Announces Exercise of Over-Allotment Option

Mainz Biomed N.V. today announced the underwriters have exercised their over-allotment option resulting in the issuance of an additional 300,000 shares.

November 8, 2021
·
3 min read
Business

SI-BONE, Inc. Reports Third Quarter 2021 Financial Results and Updates 2021 Financial Guidance

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended September 30, 2021.

November 8, 2021
·
5 min read
Business

Allakos Provides Business Update and Reports Third Quarter 2021 Financial Results

Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today provided a business update and reported financial results for the third quarter ended September 30, 2021.

November 8, 2021
·
6 min read
Biotech Bay

Revolution Medicines to Participate in Stifel 2021 Virtual Healthcare Conference

Revolution Medicines, Inc., a clinical-stage precision oncology company focused on developing targeted drugs to inhibit frontier targets that drive and sustain RAS-addicted cancers, announced that the company will participate in the upcoming Stifel 2021 Virtual Healthcare Conference.

November 8, 2021
·
1 min read